Published in Oncogene on July 16, 2012
Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev (2013) 2.46
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood (2014) 2.00
Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci U S A (2014) 1.85
Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol (2013) 1.84
Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci (2013) 1.81
Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Blood (2015) 1.70
Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics (2015) 1.65
Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci (2013) 1.50
Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem (2013) 1.40
Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions. Nucleic Acids Res (2014) 1.38
Exosomes in cancer: small particle, big player. J Hematol Oncol (2015) 1.29
Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Oncotarget (2013) 1.22
MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer. Onco Targets Ther (2014) 1.22
MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment. Oncogene (2015) 1.16
Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol Cancer (2014) 1.15
Host matrix modulation by tumor exosomes promotes motility and invasiveness. Neoplasia (2013) 1.14
The biology and function of exosomes in cancer. J Clin Invest (2016) 1.04
Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies. PLoS Pathog (2013) 1.04
Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells. Mol Cancer (2014) 1.01
Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release (2014) 0.98
Canonical and non-canonical barriers facing antimiR cancer therapeutics. Curr Med Chem (2013) 0.98
Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. PLoS Pathog (2015) 0.97
Focus on Extracellular Vesicles: New Frontiers of Cell-to-Cell Communication in Cancer. Int J Mol Sci (2016) 0.95
The fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review). Int J Oncol (2014) 0.93
Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Mol Cancer (2015) 0.91
Signaling by exosomal microRNAs in cancer. J Exp Clin Cancer Res (2015) 0.90
Exosomes Function in Pro- and Anti-Angiogenesis. Curr Angiogenes (2013) 0.90
Surface functionalization of exosomes using click chemistry. Bioconjug Chem (2014) 0.90
MicroRNA control of vascular endothelial growth factor signaling output during vascular development. Arterioscler Thromb Vasc Biol (2013) 0.90
Microvesicles secreted from human multiple myeloma cells promote angiogenesis. Acta Pharmacol Sin (2013) 0.89
Pancreatic cancer diagnosis by free and exosomal miRNA. World J Gastrointest Pathophysiol (2013) 0.89
miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity. Oncotarget (2015) 0.87
The emerging roles of tumor-derived exosomes in hematological malignancies. Leukemia (2017) 0.87
Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases. Biogerontology (2014) 0.87
Cross Talk between Cancer and Mesenchymal Stem Cells through Extracellular Vesicles Carrying Nucleic Acids. Front Oncol (2016) 0.86
Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes. Cancer Lett (2015) 0.85
MicroRNAs in placental health and disease. Am J Obstet Gynecol (2015) 0.85
The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids. J Cell Mol Med (2015) 0.85
Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells. Oncogene (2016) 0.84
Telomeric repeat-containing RNA (TERRA) constitutes a nucleoprotein component of extracellular inflammatory exosomes. Proc Natl Acad Sci U S A (2015) 0.84
Transfer of microRNAs by extracellular membrane microvesicles: a nascent crosstalk model in tumor pathogenesis, especially tumor cell-microenvironment interactions. J Hematol Oncol (2015) 0.84
MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy. Viruses (2012) 0.84
Tumor-Derived Exosomes and Their Role in Cancer Progression. Adv Clin Chem (2016) 0.83
Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin. J Control Release (2015) 0.83
Isolation of human trophoblastic extracellular vesicles and characterization of their cargo and antiviral activity. Placenta (2016) 0.83
Exosomal miRNAs as cancer biomarkers and therapeutic targets. J Extracell Vesicles (2016) 0.83
Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype. Cancer Biol Ther (2015) 0.82
Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer. Oncotarget (2017) 0.81
Role of Extracellular Vesicles in Hematological Malignancies. Biomed Res Int (2015) 0.81
The functions and clinical applications of tumor-derived exosomes. Oncotarget (2016) 0.81
Inhibition of MicroRNA miR-92a Inhibits Cell Proliferation in Human Acute Promyelocytic Leukemia. Turk J Haematol (2013) 0.81
MicroRNAs in extracellular vesicles: potential cancer biomarkers. J Hum Genet (2016) 0.81
Extracellular vesicle-mediated cell-cell communication in haematological neoplasms. Philos Trans R Soc Lond B Biol Sci (2018) 0.80
miR-182, of the miR-183 cluster family, is packaged in exosomes and is detected in human exosomes from serum, breast cells and prostate cells. Oncol Lett (2016) 0.80
Essential role of miRNAs in orchestrating the biology of the tumor microenvironment. Mol Cancer (2016) 0.80
Cellular communication via nanoparticle-transporting biovesicles. Nanomedicine (Lond) (2013) 0.79
MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases. Best Pract Res Clin Endocrinol Metab (2016) 0.78
Emerging roles of exosomes in cancer invasion and metastasis. BMB Rep (2016) 0.78
Extracellular miR-1246 promotes lung cancer cell proliferation and enhances radioresistance by directly targeting DR5. Oncotarget (2016) 0.78
MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma. Sci Rep (2017) 0.78
Functional Roles for Exosomal MicroRNAs in the Tumour Microenvironment. Comput Struct Biotechnol J (2016) 0.77
Exosomes derived from gefitinib-treated EGFR-mutant lung cancer cells alter cisplatin sensitivity via up-regulating autophagy. Oncotarget (2016) 0.77
Oncogenic epithelial cell-derived exosomes containing Rac1 and PAK2 induce angiogenesis in recipient endothelial cells. Oncotarget (2016) 0.77
Cx25 contributes to leukemia cell communication and chemosensitivity. Oncotarget (2015) 0.76
ATL-derived exosomes modulate mesenchymal stem cells: potential role in leukemia progression. Retrovirology (2016) 0.76
The emerging roles of exosomes in leukemogeneis. Oncotarget (2016) 0.76
Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma. Oncotarget (2016) 0.76
Exosome: A Novel Approach to Stimulate Bone Regeneration through Regulation of Osteogenesis and Angiogenesis. Int J Mol Sci (2016) 0.76
The role of exosomes contents on genetic and epigenetic alterations of recipient cancer cells. Iran J Basic Med Sci (2016) 0.75
Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype via exosomal miR-21. Oncotarget (2016) 0.75
Biological mechanisms of gold nanoparticle radiosensitization. Cancer Nanotechnol (2017) 0.75
Extracellular vesicles-mediated noncoding RNAs transfer in cancer. J Hematol Oncol (2017) 0.75
MicroRNAs: Lines of communication. Nat Rev Cancer (2012) 0.75
Pulmonary microRNA profiles identify involvement of Creb1 and Sec14l3 in bronchial epithelial changes in allergic asthma. Sci Rep (2017) 0.75
Tumour cell-derived exosomes endow mesenchymal stromal cells with tumour-promotion capabilities. Oncogene (2016) 0.75
Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells. Oncotarget (2016) 0.75
Bone Marrow Microenvironment Niche Regulates miR-221/222 in Acute Lymphoblastic Leukemia. Mol Cancer Res (2016) 0.75
Selective extracellular vesicle exclusion of miR-142-3p by oral cancer cells promotes both internal and extracellular malignant phenotypes. Oncotarget (2017) 0.75
Small RNA Sequencing in Cells and Exosomes Identifies eQTLs and 14q32 as a Region of Active Export. G3 (Bethesda) (2016) 0.75
Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones. Oncotarget (2016) 0.75
Exosomes derived from bone marrow stromal cells decrease the sensitivity of leukemic cells to etoposide. Oncol Lett (2017) 0.75
Endothelial Extracellular Vesicles-Promises and Challenges. Front Physiol (2017) 0.75
Biodistribution, Uptake and Effects Caused by Cancer-Derived Extracellular Vesicles. J Circ Biomark (2015) 0.75
Isolation and Identification of miRNAs in exosomes derived from serum of colon cancer patients. J Cancer (2017) 0.75
Roles of exosomes in the normal and diseased eye. Prog Retin Eye Res (2017) 0.75
International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood (1997) 20.41
CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev (1998) 11.86
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature (1998) 11.41
The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol (2001) 7.73
Cloning of mammalian Ire1 reveals diversity in the ER stress responses. EMBO J (1998) 5.96
Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett (1976) 3.35
Detection of intraoperative incidents by electronic scanning of computerized anesthesia records. Comparison with voluntary reporting. Anesthesiology (1996) 3.28
The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat Genet (1996) 3.05
Identification of novel stress-induced genes downstream of chop. EMBO J (1998) 2.93
Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts. Science (2013) 2.87
Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat Genet (1996) 2.78
The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients. Leukemia (2005) 2.71
Isolation and characterization of four plasmids from Bacillus subtilis. J Bacteriol (1977) 2.59
Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg (1999) 2.51
ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot (Tokyo) (1976) 2.42
Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum Genet (1998) 2.27
Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev (1992) 2.05
Solitary fibrous tumour: significance of p53 and CD34 immunoreactivity in its malignant transformation. Histopathology (1998) 2.00
Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis. Leukemia (2002) 1.85
CHOP-Dependent stress-inducible expression of a novel form of carbonic anhydrase VI. Mol Cell Biol (1999) 1.68
Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer (2001) 1.65
Energy landscape of a peptide consisting of alpha-helix, 3(10)-helix, beta-turn, beta-hairpin, and other disordered conformations. Protein Sci (2001) 1.64
Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation. J Biol Chem (1999) 1.64
Primary sclerosing cholangitis with marked eosinophilic infiltration in the liver. J Gastroenterol (1995) 1.61
Control of tryptophan synthetase amplified by varying the numbers of composite plasmids in Escherichia coli cells. Gene (1977) 1.58
Antimonite is accumulated by the glycerol facilitator GlpF in Escherichia coli. J Bacteriol (1997) 1.57
WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia. FEBS Lett (1980) 1.55
CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim Biophys Acta (1986) 1.55
Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group. J Clin Oncol (2000) 1.53
Myelodysplastic syndrome accompanied by Addison's disease and multiple autoimmune phenomena: steroid therapy resolved cytopenias and all immune disorders. Intern Med (2001) 1.51
Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q. Leukemia (2010) 1.48
Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals. Biochim Biophys Acta (1979) 1.47
Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Eur J Biochem (1977) 1.47
Impact of tumor size on the clinical outcomes of patients with Robson State I renal cell carcinoma. Cancer (1999) 1.47
Interstitial pneumonia in Hermansky-Pudlak syndrome: significance of florid foamy swelling/degeneration (giant lamellar body degeneration) of type-2 pneumocytes. Virchows Arch (2000) 1.44
An autopsy case of Wegener's granulomatosis with pachymeningitis. Intern Med (1998) 1.43
Regulation of insulin-stimulated glucose transport in the isolated rat adipocyte. cAMP-independent effects of lipolytic and antilipolytic agents. J Biol Chem (1987) 1.42
Analysis of peripheral blood mononuclear cell stimulated with pyruvate dehydrogenase complex, T-cell receptors from patients with primary biliary cirrhosis. J Gastroenterol (1998) 1.41
Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two? Leukemia (1993) 1.41
Urinary erythrocyte volume analysis: a simple method for localizing the site of hematuria in pediatric patients. J Pediatr (1989) 1.41
All-trans-retinoic acid induced enrichment of functionally normal neutrophils in vivo in a patient with acute promyelocytic leukemia. Leukemia (1992) 1.39
Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia. Leuk Res (2000) 1.39
The in vitro effects of all-trans-retinoic acid and hematopoietic growth factors on the clonal growth and self-renewal of blast stem cells in acute promyelocytic leukemia. Leuk Res (1997) 1.38
Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia. Oncogene (2006) 1.37
Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma. J Hepatol (1997) 1.36
Substructure and higher structure of chicken smooth muscle alpha-actinin molecule. J Biol Chem (1988) 1.30
Counter-regulation of insulin-stimulated glucose transport by catecholamines in the isolated rat adipose cell. J Biol Chem (1984) 1.29
Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters. Gene Ther (2007) 1.28
Note on vagus stimulation of the adrenalised heart. J Physiol (1915) 1.27
For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia (1999) 1.27
Molecular cloning of two new heat shock genes related to the hsp70 genes in Staphylococcus aureus. J Bacteriol (1994) 1.25
Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Atherosclerosis (1979) 1.25
Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res (1986) 1.22
MEIS1 and HOXA7 genes in human acute myeloid leukemia. Leuk Res (2000) 1.18
Phenotypic diversity of neurofibromatosis 2: association with plexiform schwannoma. Histopathology (1998) 1.18
Follicular dendritic cell tumor in the oro-pharyngeal region: report of a case and a review of the literature. Oral Oncol (2003) 1.17
The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. Leukemia (1999) 1.15
Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells. Br J Cancer (2009) 1.15
Cardiac metastasis from squamous cell carcinoma of gallbladder. J Gastroenterol (1997) 1.15
Hypolipidemic effects in monkeys of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Lipids (1979) 1.14
Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res (1994) 1.13
Genetic manipulation of membrane phospholipid composition in Escherichia coli: pgsA mutants defective in phosphatidylglycerol synthesis. Proc Natl Acad Sci U S A (1985) 1.12
An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice. Inflamm Res (2004) 1.12
Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand J Gastroenterol (2004) 1.10
Mucinous cystadenocarcinoma in the appendix in a patient with nonrotation: report of a case. Surg Today (2001) 1.09
Quantitative autistic traits ascertained in a national survey of 22 529 Japanese schoolchildren. Acta Psychiatr Scand (2012) 1.09
An on-line differential converter, for obtaining the first derivative of absorption spectra. Anal Biochem (1971) 1.08
The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats. Biochim Biophys Acta (1995) 1.08
Cytogenetic characterization of putative human myeloblastic leukemia cell lines (ML-1, -2, and -3): origin of the cells. Cancer Res (1986) 1.06
Structures of TMC-95A-D: novel proteasome inhibitors from Apiospora montagnei sacc. TC 1093. J Org Chem (2000) 1.06
Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains. Arch Dermatol Res (2000) 1.06
Corn kernel cysteine proteinase inhibitor as a novel cystatin superfamily member of plant origin. Molecular cloning and expression studies. Eur J Biochem (1992) 1.05
MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis. Br J Cancer (2013) 1.05
Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes. Clin Cancer Res (1999) 1.03
Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits. Biochim Biophys Acta (1988) 1.03
Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia (1993) 1.03
Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection. Br J Cancer (2006) 1.03
Interstitial pneumonia induced by imatinib mesylate: pathologic study demonstrates alveolar destruction and fibrosis with eosinophilic infiltration. Leukemia (2004) 1.03
Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms. Leukemia (2007) 1.01
Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders. Blood Cancer J (2012) 1.01
Metalloid resistance mechanisms in prokaryotes. J Biochem (1998) 1.01
Change of actin isomers during differentiation of smooth muscle. Biochim Biophys Acta (1985) 1.00
Anomalous cadherin expression in osteosarcoma. Possible relationships to metastasis and morphogenesis. Am J Pathol (1999) 1.00
Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Biochim Biophys Acta (1990) 1.00
Nuclear accumulation of beta-catenin in intestinal-type gastric carcinoma: correlation with early tumor invasion. Virchows Arch (2000) 0.99
beta-actinin, a regulatory protein of muscle. Purification, characterization and function. J Biochem (1977) 0.99
The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours. Int J Hyperthermia (2003) 0.99
Trisomy 11 in nonlymphocytic neoplasia. Br J Haematol (1988) 0.98
Identification and cloning of two novel allergens from the lipophilic yeast, Malassezia furfur. Biochem Biophys Res Commun (1998) 0.98
Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5;12)(q31;p13). Genes Chromosomes Cancer (1999) 0.98
Molecular characterization of the gene operon of heat shock proteins HSP60 and HSP10 in methicillin-resistant Staphylococcus aureus. Biochem Biophys Res Commun (1993) 0.97
Molecular cloning and sequencing of a cDNA of rat dopa decarboxylase: partial amino acid homologies with other enzymes synthesizing catecholamines. Proc Natl Acad Sci U S A (1989) 0.97
Updated concepts and treatment of carcinoma in situ. Urol Oncol (2011) 0.96